Brii Biosciences Announces First Subject Dosed in Phase 1 Clinical Trial of BRII-297, Long-Acting Injectable for the Treatment of Anxiety and Depressive Disorders

/PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient...

Related Keywords

Beijing ,China ,Australia ,Lianhong Xu ,Brii Bio ,Brii Biosciences Limited Bio ,Brii Biosciences Limited ,